Elizabeth M La

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 19

Top Venues

Human vaccines & immunotherapeutics

Infectious diseases and therapy

PharmacoEconomics - open

European journal of cancer care

RTI Health Solutions

University of North Carolina at Chapel Hill (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

RTI Health Solutions Jan 06 2014

United States

Associate Director :: Health Economics

Education History

University of North Carolina at Chapel Hill Aug 01 2008 - Dec 31 2013

United States

PHD :: Health Policy and Management

Publications

Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy 13 (4) (2024)
Daniel Molnar, Elizabeth M La, Frederik Verelst, Sara Poston, Jonathan Graham, Laure-Anne Van Bellinghen, Desmond Curran
Public Health Impact of the Adjuvanted RSVPreF3 Vaccine for Respiratory Syncytial Virus Prevention Among Older Adults in the United States. Infectious diseases and therapy (2024)
Ahmed Ehab Salem, Elizabeth M La, Desmond Curran, Brandon J Patterson, Justin Carrico, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Cost-Effectiveness of Recombinant Zoster Vaccine for the Prevention of Herpes Zoster in Hematopoietic Stem Cell Transplant Recipients and Other Immunocompromised Adults in the United States. PharmacoEconomics - open (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Brandon J Patterson, Justin Carrico, Ahmed Ehab Salem, Elizabeth M La, Stéphane Lorenc, Katherine A Hicks, Sara Poston, Christopher F Carpenter
Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer. Human vaccines & immunotherapeutics 19 (1) (2023)
Desmond Curran, Elizabeth M La, Ahmed Ehab Salem, David Singer, Nicolas Lecrenier, Sara Poston
Modeled impact of the COVID-19 pandemic and associated reduction in adult vaccinations on herpes zoster in the United States. Human vaccines & immunotherapeutics 18 (1) (2022)
Anita J Brogan, Sandra E Talbird, Ashley E Davis, Elizabeth M La, Princy N Kumar
The Cost-Effectiveness and Budget Impact of Ibalizumab-uiyk for Adults with Multidrug-Resistant HIV-1 Infection in the United States. PharmacoEconomics 39 (4) (2021)
Diana Garbinsky, Shannon Hunter, Elizabeth M La, Sara Poston, Cosmina S Hogea
State-Level Variations and Factors Associated with Adult Vaccination Coverage: A Multilevel Modeling Approach. PharmacoEconomics - open 5 (3) (2021)
Sandra E Talbird, Elizabeth M La, Justin Carrico, Sara Poston, Jean-Etienne Poirrier, Jessica K DeMartino, Cosmina S Hogea
Impact of population aging on the burden of vaccine-preventable diseases among older adults in the United States. Human vaccines & immunotherapeutics 17 (2) (2020)
Elizabeth M La, Sandra E Talbird, Koren V Kanadanian, Liping Huang, Joel Fain, Amit Srivastava
Cost calculator for mass vaccination response to a US college campus outbreak of serogroup B meningococcal disease. Human vaccines & immunotherapeutics 15 (4) (2019)
Sandra E Talbird, Elizabeth M La, Josephine Mauskopf, Alexandra Altland, Vincent J Daniels, Lara J Wolfson
Understanding the role of exogenous boosting in modeling varicella vaccination. Expert review of vaccines 17 (11) (2018)
Elizabeth M La, Emily Nash Smyth, Sandra E Talbird, Li Li, James A Kaye, Aimee Bence Lin, Lee Bowman
Treatment patterns and health care resource use in patients receiving multiple lines of therapy for metastatic squamous cell carcinoma of the head and neck in the United Kingdom. European journal of cancer care 27 (5) (2018)

Elizabeth M La.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Elizabeth M La